News

InSphero announces financing round with ZEISS Ventures

Great news from our portfolio company InSphero, the global market leader in 3D spheroids and cell-based assays for pharmaceutical drug discovery and safety testing.

The company has announced the successful completion of an eight-figure financing round led by ZEISS Ventures and with participation from existing and new investors.

The funds are used to advance the development and availability of cryopreserved assay-ready plates for 3D spheroid assays, enabling laboratories to store these plates for rapid access, thereby streamlining research and drug development processes. For ZEISS Ventures it is as a strategic investment closely linked to ZEISS Research Microscopy Solutions.

More information in the press release under the following Link

More about InSphero

Resistell collaborates with CRISP Overview adivo starts clinical study
Want to learn more about OCCIDENT?

News

About

New OCCIDENT Website

Having sharpened our investor profile and revised our communi­cation, we get to the point: OCCIDENT – The Science Investor.